Healthcare Utilization and Costs for Huntington Disease Patients Prescribed Tetrabenazine

被引：0
|
作者：
Anderson, Karen E. [1 ]
Iyer, Ravi [2 ]
Gandhi, Sanjay [2 ]
Abler, Victor [2 ]
Davis, Brian [3 ]
Irwin, Debra [3 ]
Sung, Victor [4 ]
机构：
[1] Georgetown Univ Hosp, Washington, DC 20007 USA
[2] Teva Pharmaceut Ind, Frazer, PA USA
[3] Truven Hlth Analyt, Cambridge, MA USA
[4] Univ Alabama, Birmingham, AL USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.044
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Health related quality of life, service utilization and costs for patients with Huntington’s disease in Norway
    Marleen R. van Walsem
    Jan C. Frich
    Monica Gómez Castañeda
    Emilie Isager Howe
    Lasse Pihlstrøm
    Nada Andelic
    Eline Aas
    BMC Health Services Research, 22
  • [32] Tetrabenazine: Impact on Impulsivity Scales in Huntington's Disease
    Ondo, William
    Arif, Chia
    Williams, Bethany
    Podel, Kenneth
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 36 - 36
  • [33] Evaluating depression and suicidality in tetrabenazine users with Huntington disease
    Schultz, Jordan L.
    Killoran, Annie
    Nopoulos, Peg C.
    Chabal, Chloe C.
    Moser, David J.
    Kamholz, John A.
    NEUROLOGY, 2018, 91 (03) : E202 - E207
  • [34] Tetrabenazine treatment for Huntington's disease - Associated chorea
    Ondo, WG
    Tintner, R
    Thomas, M
    Jankovic, J
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (06) : 300 - 302
  • [35] Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease
    Claassen, Daniel O.
    Ayyagari, Rajeev
    Garcia-Horton, Viviana
    Zhang, Su
    Alexander, Jessica
    Leo, Sam
    NEUROLOGY, 2021, 96 (15)
  • [36] Alzheimer's disease increases healthcare utilization and costs in patients with common medical comorbidities
    Fillit, H
    Hill, JW
    Futterman, R
    Lloyd, JR
    Mastey, V
    NEUROLOGY, 2002, 58 (07) : A486 - A487
  • [37] Alzheimer's disease increases healthcare utilization and costs in patients with common medical comorbidities
    Fillit, H
    Hill, JW
    Futterman, R
    Lloyd, JR
    Mastey, V
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S50 - S50
  • [38] Impact of fistula on healthcare resource utilization and costs among patients with Crohn's disease
    Dabbous, O.
    Arjunji, R.
    Gdovin, J.
    Thompson, H.
    Tang, B.
    Rahman, M.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 660 - 661
  • [39] Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy
    Petta, Salvatore
    Ting, Jie
    Saragoni, Stefania
    Degli Esposti, Luca
    Shreay, Sanatan
    Petroni, Maria Letizia
    Marchesini, Giulio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (06) : 1014 - 1022
  • [40] Healthcare Utilization and Costs for Patients With Parkinson's Disease After Deep Brain Stimulation
    Stroupe, Kevin T.
    Smith, Bridget
    Weaver, Frances M.
    Gonzalez, Beverly
    Huo, Zhiping
    Cao, Lishan
    Ippolito, Dolores
    Follett, Kenneth A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (05): : 369 - 378
12345